A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer

StatusActive, Not Recruiting
PhasePhase 2
Started

Record status This record was last updated November 4, 2025 (before its estimated October 19, 2026 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Oct 19, 2025 to Oct 19, 2026v13
  2. Re-verified, no change to tracked fieldsv12
  3. Primary and study completion dates: Oct 19, 2024 to Oct 19, 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 7 of 7 sites
    v11
  4. 2 versions Re-verified since Dec 1, 2023, no change to tracked fieldsv9-v10
  5. Site contacts updated at 1 of 7 sitesv8
Show 6 earlier versionsHide 6 earlier versions
  1. Re-verified, no change to tracked fieldsv7
  2. Eligibility criteria revisedv6
  3. Re-verified, no change to tracked fieldsv5
  4. Study sites: 1 to 7v4
  5. Re-verified, no change to tracked fieldsv3
  6. Secondary endpoints: 1 to 4v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to find out whether combining a shorter than standard course of ADT with standard prostate brachytherapy and hypofractionated external beam radiation therapy is a safe and effective way to prevent high-risk prostate cancer from coming back and/or spreading to other parts of the body.
Trial Details
NCT Number NCT05100472
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions
(from sponsor)		 Prostate Cancer
Related terms Prostatic Neoplasms
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov